脂肪功能障碍、脂质失调与脂肪因子在肌少症中的作用:系统综述与性别特异性荟萃分析
肌少症与LDL-C轻度升高相关(SMD=0.13;P=.0022),女性更明显(SMD=0.46);女性HDL-C显著升高(SMD=6.71;P=.03);腰围、肌肉指数有变化,甘油三酯、总胆固醇、脂联素、瘦素及炎症标志物无显著关联。
要点
- 肌少症与LDL-C轻度升高相关,女性效应更明显(SMD=0.46)。
- 女性肌少症患者HDL-C显著升高(SMD=6.71;P=.03)。
- 腰围在肌少症中显著增加(SMD=5.82 cm;P=.25)。
核心结论
- 肌少症与LDL-C轻度升高相关,尤其在女性中更明显,女性HDL-C显著升高,提示需性别靶向干预。
研究设计与样本
- 采用随机效应荟萃分析和荟萃回归,用I2统计量评估异质性,用漏斗图和Trim-and-Fill程序评估发表偏倚。
- 方案在PROSPERO注册(CRD42024626636)。
主要发现
- 肌少症与LDL-C轻度升高相关(SMD=0.13;P=.0022),女性中更明显(SMD=0.46)。
- 女性HDL-C水平显著升高(SMD=6.71;P=.03)。
- 腰围显著增加(SMD=5.82 cm;P=.25),肌肉指数(SMI、ASMI、SMM)在肌少症中较低。
- 甘油三酯、总胆固醇、脂联素、瘦素及炎症标志物(TNF-α、IL-6、IL-8)无显著关联。
- 亚组分析显示性别、测量方法和肌少症定义有显著影响,荟萃回归提示这些因素影响脂质标志物变化。
临床怎么用
- 在肌少症评估中可关注血脂谱,尤其女性LDL-C和HDL-C变化,考虑性别特异性干预。
- 腰围和肌肉指数(SMI、ASMI、SMM)可作为肌少症相关评估指标。
局限性
- 需要进一步纵向研究阐明因果关系并优化肌少症临床管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sarcopenia is increasingly recognised as a systemic metabolic disorder involving lipid dysregulation, adipose tissue dysfunction, and adipokine imbalance. However, there is a lack of quantitative synthesis with sex-specific analyses. METHODS: Following PRISMA 2020 guidelines, we searched PubMed, Scopus, Web of Science, Cochrane Library, CNKI, WanFang, and VIP for studies published from January 2015 to December 2024 that compared lipid panels, adipokines, adiposity, muscle indices, and inflammatory markers in sarcopenic and non-sarcopenic adults. Random-effects meta-analyses and meta-regression were performed. Heterogeneity was assessed using I2 statistics, and publication bias was evaluated with funnel plots and Trim-and-Fill procedures. RESULTS: Fifty-two studies (N > 30 000) met the inclusion criteria. Sarcopenia was associated with a modest increase in LDL-C (SMD = 0.13; P = .0022), particularly in females (SMD = 0.46). HDL-C levels significantly increased in females (SMD = 6.71; P = .03). No significant changes were observed for triglycerides, total cholesterol, adiponectin, or leptin. Waist circumference increased significantly (SMD = 5.82 cm; P = .25), and muscle indices (SMI, ASMI, SMM) were lower in sarcopenia. Inflammatory markers (TNF-α, IL-6, IL-8) showed no significant associations. Subgroup analyses revealed significant effects by sex, measurement methods, and sarcopenia definitions, with meta-regression indicating these factors influenced lipid marker changes. CONCLUSION: This meta-analysis integrates lipid fractions, adipokines, adiposity markers, and sex-specific differences in sarcopenia. Our findings highlight the significant rise in HDL-C in females and suggest the need for sex-targeted interventions. Further longitudinal studies are needed to clarify causality and refine clinical practice in sarcopenia management. The protocol was registered on PROSPERO (CRD42024626636).
引用
- Arthur Vithran DT, Hassan MHY, Rahmati M, et al. Adipose dysfunction, lipid dysregulation, and adipokines in sarcopenia: a systematic review and meta-analysis with sex-specific analyses. Age Ageing. 2026. PMID: 41642178. doi:10.1093/ageing/afag020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。